Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(10):1005-1014.
doi: 10.2174/0115680096281168231215060301.

The Role of Bile Acids in Pancreatic Cancer

Affiliations
Review

The Role of Bile Acids in Pancreatic Cancer

Yanling Wang et al. Curr Cancer Drug Targets. 2024.

Abstract

Bile acids are well known to promote the digestion and absorption of fat, and at the same time, they play an important role in lipid and glucose metabolism. More studies have found that bile acids such as ursodeoxycholic acid also have anti-inflammatory and immune-regulating effects. Bile acids have been extensively studied in biliary and intestinal tumors but less in pancreatic cancer. Patients with pancreatic cancer, especially pancreatic head cancer, are often accompanied by biliary obstruction and elevated bile acids caused by tumors. Elevated total bile acid levels in pancreatic cancer patients usually have a poor prognosis. There has been controversy over whether elevated bile acids are harmful or beneficial to pancreatic cancer. Still, there is no doubt that bile acids are important for the occurrence and development of pancreatic cancer. This article summarizes the research on bile acid as a biomarker and regulation of the occurrence, development and chemoresistance of pancreatic cancer, hoping to provide some inspiration for future research.

Keywords: Bile acids; biomarker; carcinogenesis; chemoresistance.; pancreatic cancer; progression of cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Luo W.; Tao J.; Zheng L.; Zhang T.; Current epidemiology of pancreatic cancer: Challenges and opportunities. Chin J Cancer Res 2020,32(6),705-719 - DOI - PubMed
    1. Siegel R.L.; Miller K.D.; Fuchs H.E.; Jemal A.; Cancer statistics, 2021. CA Cancer J Clin 2021,71(1),7-33 - DOI - PubMed
    1. Rahib L.; Smith B.D.; Aizenberg R.; Rosenzweig A.B.; Fleshman J.M.; Matrisian L.M.; Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014,74(11),2913-2921 - DOI - PubMed
    1. Cai J.; Chen H.; Lu M.; Zhang Y.; Lu B.; You L.; Zhang T.; Dai M.; Zhao Y.; Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett 2021,520,1-11 - DOI - PubMed
    1. Kleeff J.; Korc M.; Apte M.; La Vecchia C.; Johnson C.D.; Biankin A.V.; Neale R.E.; Tempero M.; Tuveson D.A.; Hruban R.H.; Neoptolemos J.P.; Pancreatic cancer. Nat Rev Dis Primers 2016,2(1),16022 - DOI - PubMed